Showing 1 to 3 of 3 results


Prostate Cancer Screening Guidelines: A Personalized Approach
The US Preventive Services Task Force recommends prostate cancer screening discussions for men aged 55-69, but not for those over 70; however, doctors recommend individual discussions with healthcare providers to weigh benefits and risks, noting potential for overtreatment and varying guidelines.
Prostate Cancer Screening Guidelines: A Personalized Approach
The US Preventive Services Task Force recommends prostate cancer screening discussions for men aged 55-69, but not for those over 70; however, doctors recommend individual discussions with healthcare providers to weigh benefits and risks, noting potential for overtreatment and varying guidelines.
Progress
48% Bias Score


PSA Test and Prostate Cancer Screening: Benefits, Drawbacks, and Future Directions
The article discusses the ongoing debate surrounding the use of PSA tests for prostate cancer screening, highlighting the benefits and drawbacks and the need for a more targeted approach.
PSA Test and Prostate Cancer Screening: Benefits, Drawbacks, and Future Directions
The article discusses the ongoing debate surrounding the use of PSA tests for prostate cancer screening, highlighting the benefits and drawbacks and the need for a more targeted approach.
Progress
0% Bias Score

Rise in Prostate Cancer Diagnoses Raises Questions About Screening and Treatment
Prostate cancer has become the most common cancer diagnosis in England, prompting increased PSA testing despite studies showing limited effectiveness of widespread screening and treatment uncertainties highlighted by the British ProtecT study.

Rise in Prostate Cancer Diagnoses Raises Questions About Screening and Treatment
Prostate cancer has become the most common cancer diagnosis in England, prompting increased PSA testing despite studies showing limited effectiveness of widespread screening and treatment uncertainties highlighted by the British ProtecT study.
Progress
36% Bias Score
Showing 1 to 3 of 3 results